Christina L. Chai
16 Medical Drive
117600, Singapore
117600, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Evaluating Molecular Docking Programs for RNA-Targeted Ligand Screening: Influence of Binding Modes and Ligand Types.
Journal: Journal of chemical information and modeling
Published: May 12, 2026
The futility of the familiar: rethinking strategies for the development of small molecules for neurodegenerative disorders.
Journal: Expert opinion on drug discovery
Published: March 16, 2026
Mutagenesis-Guided Target Identification Reveals the Protein-Binding Domain of Nsp14 in Coronaviruses as the Target of a Labdane-Oxindole Compound.
Journal: ACS infectious diseases
Published: April 10, 2025
Privileged natural product compound classes for anti-inflammatory drug development.
Journal: Natural product reports
Published: March 11, 2025
Calcaratarin D, a labdane diterpenoid, attenuates bleomycin-induced pulmonary fibrosis by blocking Wnt/β-catenin signaling pathway.
Journal: Pharmacological research
Published: March 04, 2025
Identification of Small-Molecule Inhibitors for Enterovirus A71 IRES by Structure-Based Virtual Screening.
Journal: Journal of chemical information and modeling
Published: March 01, 2025
Degradation of MK2 with natural compound andrographolide: A new modality for anti-inflammatory therapy.
Journal: Pharmacological research
Published: May 05, 2023
Calcaratarin D, a labdane diterpenoid, attenuates mouse asthma via modulating alveolar macrophage function.
Journal: British journal of pharmacology
Published: June 26, 2022
COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?
Journal: Pharmacological research
Published: February 08, 2022
Discovery and development of labdane-oxindole hybrids as small-molecule inhibitors against chikungunya virus infection.
Journal: European journal of medicinal chemistry
Published: December 01, 2021
Last Updated: 09/26/2026